The Welsh Government recently sought comments on a series of recommendations for the improvement of the appraisal process of orphan and ultra-orphan medicines in Wales. The Society…
The National Institute for Health and Care Excellence (NICE) has consulted on the scope (i.e. what aspects of care the guideline will cover and to whom it will apply) of the clinical…
The Commons Select Science and Technology Committee held an inquiry into antimicrobial resistance. BPS responded to highlight the need to incentivise development of new…
HEFCE (Higher Education Funding Council for England) ran a consultation on open access requirements for the post-2014 REF (following on from the informal request for advice in…
MHRA (Medicines and Healthcare Products Regulatory Agency) ran a consultation on the continued availability of diclofenac as a Pharmacy (P) medicine and on the risk minimisation…
The Home Office ran a consultation on the scheduling of tramadol under the Misuse of Drugs Regulations 2001. This followed a Ministerial decision, in principle, to accept the ACMD's…
The European Medicines Agency (EMA) ran a consultation to discuss their proposed policy for access to clinical trial data for data submitted to the EMA from January 2014. BPS noted…
The Commons Select Science and Technology Committee held an inquiry on the ‘leaky pipeline’ i.e. the continuous loss of women at consecutive career stages within STEM industries. The…
The Society responded to the Ethical Standards in the Health & Life Sciences Group’s (ESHLSG) consultation to highlight our support for declaration of payments made to healthcare…
The Finch Group met in September 2013 to review progress in implementing the recommendations from the report. In order to inform this review meeting, we responded to the Society of…
